| Drug Name |
Icosapent ethyl |
| Drug ID |
BADD_D01126 |
| Description |
Icosapent ethyl or ethyl eicosapentaenoic acid is a synthetic derivative of the omega-3 fatty acid eicosapentaenoic acid (EPA). It is used as adjunct therapy for severe hypertriglyceridemia (TG levels > 500 mg/dL). FDA approved on July 26, 2012. |
| Indications and Usage |
Icosapent ethyl is used as adjunct therapy to reduce triglyceride (TG) levels in adults with severe (>500 mg/dL) hypertriglyceridemia. |
| Marketing Status |
Prescription |
| ATC Code |
Not Available |
| DrugBank ID |
DB08887
|
| KEGG ID |
D01892
|
| MeSH ID |
C035276
|
| PubChem ID |
9831415
|
| TTD Drug ID |
Not Available
|
| NDC Product Code |
44585-0003; 63629-8247; 11014-0430; 68279-001; 52937-001; 43598-267; 62009-0908; 52937-101; 52671-001; 10888-8142; 68279-002; 10888-8216; 60505-4033; 52937-003; 55209-1008; 0054-0508; 10888-8186; 68197-0006; 10888-8141; 71215-102; 10888-8143; 11014-0002; 10888-8198; 71215-101; 79568-000 |
| Synonyms |
eicosapentaenoic acid ethyl ester | 5,8,11,14,17-eicosapentaenoic acid, ethyl ester, (5Z,8Z,11Z,14Z,17Z)- | ethyl (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate | ethyl-EPA | ethyl eicosapentaenoate | ethyl icosapentaenoate | ethyl eicosapentaenoic acid | ethyl-eicosapentaenoic acid | icosapent ethyl | ethyl all-cis-5,8,11,14,17-icosapentaenoate | Epadel | AMR-101 | AMR101 | vascepa |
